Deciduous Therapeutics (Seed+)
Funding Details
Awarder
Gaingels
Date Award
May 24, 2024
Vertical
Healthcare and Biotech
Valuation
$35,000,000
Company Info
Founders
Robin Mansukhani
Market
Healthcare & Wellness
Coinvestors
BOLD Capital Partners
Company Description

Developing multiple activation approaches to clearing senescent cells via novel immunotherapies. Deciduous Therapeutics is an aging therapeutics company developing a novel class of immune modulatory therapies.